Jewell lab awarded $1.1M from U.S. Dept. of Veterans Affairs to study vaccine for multiple sclerosis

The Jewell lab has received a 4-year, $1.1M grant from the U.S. Dept. of Veterans Affairs to design and test a vaccine-like strategy for multiple sclerosis (MS). The project will harness a new idea for reprogramming malfunctioning immune cells during MS by self-assembling immune signals to control how these signals are processed during disease. The funding will support key studies in cells, pre-clinical models of MS, and in samples from human MS patients. Dr. Jewell was recently named a non-clinical scientist at the Baltimore branch of the VA, and this grant will grow collaborations with Dr. Walter Royal at the VA Multiple Sclerosis Center of Excellence-East, as well as with Dr. Jonathan Bromberg at the University of Maryland Medical School.

Thanks to the VA Biomedical Laboratory Research and Development (BLR&D) service for this outstanding support.